DK0800383T3 - Farmaceutisk præparat, der omfatter proliposompulver til inhalation - Google Patents
Farmaceutisk præparat, der omfatter proliposompulver til inhalationInfo
- Publication number
- DK0800383T3 DK0800383T3 DK95942357T DK95942357T DK0800383T3 DK 0800383 T3 DK0800383 T3 DK 0800383T3 DK 95942357 T DK95942357 T DK 95942357T DK 95942357 T DK95942357 T DK 95942357T DK 0800383 T3 DK0800383 T3 DK 0800383T3
- Authority
- DK
- Denmark
- Prior art keywords
- inhalation
- pharmaceutical composition
- proliposome powder
- proliposome
- powder
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Dispersion Chemistry (AREA)
- Toxicology (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9404466A SE9404466D0 (sv) | 1994-12-22 | 1994-12-22 | Process for the preparation of powders for inhalation |
SE9502369A SE9502369D0 (sv) | 1995-06-30 | 1995-06-30 | Process for the preparation of compositions for inhalation |
PCT/SE1995/001560 WO1996019199A1 (fr) | 1994-12-22 | 1995-12-20 | Poudres de proliposome pour inhalations |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0800383T3 true DK0800383T3 (da) | 2003-07-07 |
Family
ID=26662194
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95942357T DK0800383T3 (da) | 1994-12-22 | 1995-12-20 | Farmaceutisk præparat, der omfatter proliposompulver til inhalation |
Country Status (32)
Country | Link |
---|---|
US (1) | US6045828A (fr) |
EP (1) | EP0800383B1 (fr) |
JP (1) | JPH10510830A (fr) |
KR (1) | KR100432461B1 (fr) |
CN (1) | CN1087932C (fr) |
AR (1) | AR002009A1 (fr) |
AT (1) | ATE240095T1 (fr) |
AU (1) | AU693632B2 (fr) |
BR (1) | BR9510512A (fr) |
CA (1) | CA2208517A1 (fr) |
CZ (1) | CZ286469B6 (fr) |
DE (1) | DE69530792T2 (fr) |
DK (1) | DK0800383T3 (fr) |
EE (1) | EE03592B1 (fr) |
EG (1) | EG23683A (fr) |
ES (1) | ES2194931T3 (fr) |
FI (1) | FI972653A (fr) |
HU (1) | HUT77628A (fr) |
IL (1) | IL116454A (fr) |
IS (1) | IS1978B (fr) |
MY (1) | MY114114A (fr) |
NO (1) | NO320434B1 (fr) |
NZ (1) | NZ298180A (fr) |
PL (1) | PL184393B1 (fr) |
PT (1) | PT800383E (fr) |
RU (1) | RU2162689C2 (fr) |
SA (1) | SA95160463B1 (fr) |
SK (1) | SK284918B6 (fr) |
TR (1) | TR199501633A1 (fr) |
TW (1) | TW508248B (fr) |
UA (1) | UA43886C2 (fr) |
WO (1) | WO1996019199A1 (fr) |
Families Citing this family (102)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR002009A1 (es) * | 1994-12-22 | 1998-01-07 | Astra Ab | Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco. |
US20020052310A1 (en) * | 1997-09-15 | 2002-05-02 | Massachusetts Institute Of Technology The Penn State Research Foundation | Particles for inhalation having sustained release properties |
TW497974B (en) * | 1996-07-03 | 2002-08-11 | Res Dev Foundation | High dose liposomal aerosol formulations |
WO1998011877A1 (fr) * | 1996-09-18 | 1998-03-26 | Dragoco, Inc. | Composition de poudre seche contenant un principe actif encapsule dans des liposomes |
US20030203036A1 (en) * | 2000-03-17 | 2003-10-30 | Gordon Marc S. | Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients |
ID24063A (id) * | 1997-06-27 | 2000-07-06 | Astra Ab | Kombinasi obat anti asma |
IL133478A0 (en) * | 1997-06-27 | 2001-04-30 | Astra Ab | Proliposome powders for inhalation stabilised by tocopherol |
US7052678B2 (en) * | 1997-09-15 | 2006-05-30 | Massachusetts Institute Of Technology | Particles for inhalation having sustained release properties |
US7348025B2 (en) | 1997-09-23 | 2008-03-25 | Research Development Foundation | Small particle liposome aerosols for delivery of anticancer drugs |
US6090407A (en) | 1997-09-23 | 2000-07-18 | Research Development Foundation | Small particle liposome aerosols for delivery of anti-cancer drugs |
US20060165606A1 (en) | 1997-09-29 | 2006-07-27 | Nektar Therapeutics | Pulmonary delivery particles comprising water insoluble or crystalline active agents |
US20020017295A1 (en) * | 2000-07-07 | 2002-02-14 | Weers Jeffry G. | Phospholipid-based powders for inhalation |
SE9704833D0 (sv) * | 1997-12-22 | 1997-12-22 | Astra Ab | New formulation |
US6956021B1 (en) * | 1998-08-25 | 2005-10-18 | Advanced Inhalation Research, Inc. | Stable spray-dried protein formulations |
EP1839648A3 (fr) * | 1998-11-12 | 2007-11-21 | Transave, Inc. | Système d'inhalation |
PL347630A1 (en) * | 1998-11-12 | 2002-04-22 | Frank G Pilkiewicz | An inhalation system |
JP3840515B2 (ja) * | 1998-11-26 | 2006-11-01 | ブリタニア・ファーマスーティカルズ・リミテッド | 界面活性リン脂質を含む抗喘息の組合せ |
GB9912639D0 (en) * | 1999-05-28 | 1999-07-28 | Britannia Pharmaceuticals Ltd | Improvements in and relating to treatment of respiratory conditions |
PL196951B1 (pl) * | 1999-03-05 | 2008-02-29 | Chiesi Farma Spa | Proszek do stosowania w inhalatorze suchego proszku, cząsteczki nośnika i sposób wytwarzania nośnika |
EP1043016B1 (fr) * | 1999-03-30 | 2014-08-20 | Sodic Sa | Extrait de plante à base de glycérides, phospholipides et phytosphingolipides, son procédé de préparation et compositions cosmétiques le renfermant |
AU773556B2 (en) | 1999-04-05 | 2004-05-27 | Mannkind Corporation | Methods for fine powder formation |
JP4937453B2 (ja) | 1999-05-27 | 2012-05-23 | ユーロ−セルティック エス. ア. | 抗感染剤および/または抗炎症剤を適用するための製剤 |
US7300667B1 (en) | 1999-05-27 | 2007-11-27 | Euro-Celtique, S.A. | Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract |
US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
US6749835B1 (en) | 1999-08-25 | 2004-06-15 | Advanced Inhalation Research, Inc. | Formulation for spray-drying large porous particles |
US20010036481A1 (en) * | 1999-08-25 | 2001-11-01 | Advanced Inhalation Research, Inc. | Modulation of release from dry powder formulations |
WO2001013891A2 (fr) * | 1999-08-25 | 2001-03-01 | Advanced Inhalation Research, Inc. | Modulation de liberation a partir de formulations seches en poudre |
US7678364B2 (en) | 1999-08-25 | 2010-03-16 | Alkermes, Inc. | Particles for inhalation having sustained release properties |
US6156294A (en) | 1999-11-28 | 2000-12-05 | Scientific Development And Research, Inc. | Composition and method for treatment of otitis media |
GB9928311D0 (en) * | 1999-11-30 | 2000-01-26 | Novartis Ag | Organic compounds |
DE10012151A1 (de) * | 2000-03-13 | 2001-09-27 | Gsf Forschungszentrum Umwelt | Mittel zur Behandlung von Erkrankungen des Tracheo-Brochialtraktes, insbesondere der COPD |
GB0008660D0 (en) * | 2000-04-07 | 2000-05-31 | Arakis Ltd | The treatment of respiratory diseases |
US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
US6777399B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
GB0019172D0 (en) | 2000-08-05 | 2000-09-27 | Glaxo Group Ltd | Novel compounds |
US6777400B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
US6759398B2 (en) | 2000-08-05 | 2004-07-06 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative |
US6858596B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
US6750210B2 (en) | 2000-08-05 | 2004-06-15 | Smithkline Beecham Corporation | Formulation containing novel anti-inflammatory androstane derivative |
US6787532B2 (en) | 2000-08-05 | 2004-09-07 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivatives |
US6858593B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
EP2283818B1 (fr) | 2000-11-30 | 2017-08-02 | Vectura Limited | Procede de preparation de particules destinees a etre utilisees dans une composition pharmaceutique |
US20020141946A1 (en) * | 2000-12-29 | 2002-10-03 | Advanced Inhalation Research, Inc. | Particles for inhalation having rapid release properties |
UA77656C2 (en) | 2001-04-07 | 2007-01-15 | Glaxo Group Ltd | S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent |
DK1455755T3 (da) * | 2001-11-20 | 2013-07-15 | Civitas Therapeutics Inc | Forbedrede partikelsammensætning til levering i lunge |
SI1458360T1 (sl) | 2001-12-19 | 2011-08-31 | Novartis Ag | Pulmonalno dajanje aminoglikozidov |
AU2003201569B2 (en) * | 2002-01-21 | 2008-09-11 | Vasogen Ireland Limited | Pharmaceutically acceptable phosphate-glycerol carrying bodies |
AU2003230600B2 (en) * | 2002-03-05 | 2009-06-04 | Transave, Inc. | An inhalation system for prevention and treatment of intracellular infections |
EP1494732B1 (fr) | 2002-03-20 | 2008-01-30 | MannKind Corporation | Appareil d'inhalation |
GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
CN1747738B (zh) * | 2002-10-29 | 2010-11-24 | 川塞夫有限公司 | 缓释抗感染剂 |
US7879351B2 (en) * | 2002-10-29 | 2011-02-01 | Transave, Inc. | High delivery rates for lipid based drug formulations, and methods of treatment thereof |
US7718189B2 (en) | 2002-10-29 | 2010-05-18 | Transave, Inc. | Sustained release of antiinfectives |
CN1208052C (zh) | 2003-03-20 | 2005-06-29 | 上海家化联合股份有限公司 | 一种辅酶q10前体脂质体及其制备方法 |
US20060147389A1 (en) * | 2004-04-14 | 2006-07-06 | Vectura Ltd. | Devices and pharmaceutical compositions for enhancing dosing efficiency |
WO2004093848A2 (fr) * | 2003-04-14 | 2004-11-04 | Vectura Ltd | Dispositifs et compositions pharmaceutiques destines a ameliorer l'efficacite de dosage |
US20040204439A1 (en) * | 2003-04-14 | 2004-10-14 | Staniforth John Nicholas | Composition, device, and method for treating sexual dysfunction via inhalation |
CN100427064C (zh) * | 2003-04-16 | 2008-10-22 | 沈阳药科大学 | 一种制备脂质体的新方法 |
ES2362038T3 (es) * | 2003-09-02 | 2011-06-27 | Norton Healthcare Limited | Procedimiento para preparar un medicamento. |
WO2005044226A2 (fr) * | 2003-11-04 | 2005-05-19 | Nectar Therapeutics | Formulations de lipides pour l'encapsulation de medicaments |
KR101273120B1 (ko) | 2004-08-20 | 2013-06-13 | 맨카인드 코포레이션 | 다이케토피페라진 합성의 촉매 작용 |
KR20130066695A (ko) | 2004-08-23 | 2013-06-20 | 맨카인드 코포레이션 | 약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염 |
GB0425758D0 (en) | 2004-11-23 | 2004-12-22 | Vectura Ltd | Preparation of pharmaceutical compositions |
IN2014DN09128A (fr) | 2005-09-14 | 2015-07-10 | Mannkind Corp | |
HUE029994T2 (en) | 2005-12-08 | 2017-04-28 | Insmed Inc | Lipid-based preparations of antinfectants for the treatment of lung infections |
BRPI0707991B8 (pt) | 2006-02-22 | 2021-05-25 | Mannkind Corp | métodos de preparação de um medicamento em pó seco com uma propriedade farmacêutica melhorada, dito pó seco e uso de uma quantidade efetiva do pó seco |
CN1895223B (zh) * | 2006-04-05 | 2012-06-27 | 沈阳药科大学 | 一种新的脂质体制备方法 |
US9814672B2 (en) * | 2007-03-09 | 2017-11-14 | Susan T. Laing | Echogenic vehicle for clinical delivery of plasminogen activator and other fibrin-binding therapeutics to thrombi |
EP2146692A1 (fr) * | 2007-03-19 | 2010-01-27 | Fresenius Kabi Oncology Limited | Compositions proliposomales et liposomales |
US20100196455A1 (en) * | 2007-05-04 | 2010-08-05 | Transave, Inc. | Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof |
US9119783B2 (en) | 2007-05-07 | 2015-09-01 | Insmed Incorporated | Method of treating pulmonary disorders with liposomal amikacin formulations |
US9333214B2 (en) | 2007-05-07 | 2016-05-10 | Insmed Incorporated | Method for treating pulmonary disorders with liposomal amikacin formulations |
US9114081B2 (en) | 2007-05-07 | 2015-08-25 | Insmed Incorporated | Methods of treating pulmonary disorders with liposomal amikacin formulations |
US20090047336A1 (en) * | 2007-08-17 | 2009-02-19 | Hong Kong Baptist University | novel formulation of dehydrated lipid vesicles for controlled release of active pharmaceutical ingredient via inhalation |
CN109568740B (zh) | 2008-06-13 | 2022-05-27 | 曼金德公司 | 干粉吸入器和用于药物输送的系统 |
US8485180B2 (en) * | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
ES2904623T3 (es) | 2008-06-20 | 2022-04-05 | Mannkind Corp | Aparato interactivo para establecer un perfil en tiempo real de esfuerzos de inhalación |
TWI494123B (zh) | 2008-08-11 | 2015-08-01 | Mannkind Corp | 超快起作用胰島素之用途 |
US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
DK2400950T3 (da) | 2009-02-26 | 2019-07-29 | Glaxo Group Ltd | Farmaceutiske formuleringer omfattende 4-{(1 r)-2-[(6-{2-[(2,6-dichlorbenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol |
PL2405963T3 (pl) | 2009-03-11 | 2014-04-30 | Mannkind Corp | Urządzenie, układ i sposób pomiaru oporu inhalatora |
KR101875969B1 (ko) | 2009-06-12 | 2018-07-06 | 맨카인드 코포레이션 | 한정된 비표면적을 갖는 디케토피페라진 마이크로입자 |
EP2496295A1 (fr) | 2009-11-03 | 2012-09-12 | MannKind Corporation | Appareil et méthode de simulation d'efforts d'inhalation |
GB0921075D0 (en) | 2009-12-01 | 2010-01-13 | Glaxo Group Ltd | Novel combination of the therapeutic agents |
KR20130117755A (ko) | 2010-06-21 | 2013-10-28 | 맨카인드 코포레이션 | 건조 분말 약물 운반 시스템 및 방법 |
JP6133270B2 (ja) | 2011-04-01 | 2017-05-24 | マンカインド コーポレイション | 薬剤カートリッジのためのブリスター包装 |
WO2012174472A1 (fr) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | Microparticules de dicétopipérazine de capacité élevée |
BR112014009686A2 (pt) | 2011-10-24 | 2018-08-07 | Mannkind Corp | composição analgésica inalável, pó seco e método para tratar dor |
US20150272880A1 (en) | 2012-05-21 | 2015-10-01 | Insmed Incorporated | Systems for treating pulmonary infections |
AU2013289957B2 (en) | 2012-07-12 | 2017-02-23 | Mannkind Corporation | Dry powder drug delivery systems and methods |
WO2014028796A2 (fr) | 2012-08-17 | 2014-02-20 | Smartek International Llc | Préparation de liposomes desséchés utilisable dans des systèmes d'administration compressibles |
EP2911690A1 (fr) | 2012-10-26 | 2015-09-02 | MannKind Corporation | Compositions et procédés de vaccin antigrippal inhalable |
BR112015012351A8 (pt) | 2012-11-29 | 2019-10-01 | Insmed Inc | composição de antibiótico de glicopeptídeo à base de lipídeo estabilizado e uso de um componente lipídico, um componente de antibiótico de glicopeptídeo e um aminoácido ou derivado do mesmo |
US9603799B2 (en) * | 2013-03-15 | 2017-03-28 | Htd Biosystems Inc. | Liposomal vaccine adjuvants and methods of making and using same |
ES2754388T3 (es) | 2013-03-15 | 2020-04-17 | Mannkind Corp | Composiciones y métodos de dicetopiperazina microcristalina |
BR122019026637B1 (pt) | 2013-07-18 | 2023-09-26 | Mannkind Corporation | Formulações farmacêuticas de pó seco e método para a fabricação de uma formulação de pó seco |
WO2015021064A1 (fr) | 2013-08-05 | 2015-02-12 | Mannkind Corporation | Appareil d'insufflation et procédés |
US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
PL3142643T3 (pl) | 2014-05-15 | 2019-12-31 | Insmed Incorporated | Sposoby leczenia zakażeń płuc prątkami niegruźliczymi |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
WO2017194454A1 (fr) * | 2016-05-09 | 2017-11-16 | Astrazeneca Ab | Nanoparticules lipidiques comprenant des agents anti-inflammatoires lipophiles et leurs procédés d'utilisation |
JP7460534B2 (ja) | 2018-03-30 | 2024-04-02 | インスメッド インコーポレイテッド | リポソーム医薬品の連続製造方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US514674A (en) * | 1894-02-13 | Ejector for breakdown guns | ||
DE2966795D1 (en) * | 1978-10-12 | 1984-04-19 | Bowater Scott Ltd | Holder and dispenser for stacked rolls |
GB2135647A (en) * | 1983-02-15 | 1984-09-05 | Squibb & Sons Inc | Method of preparing liposomes and products produced thereby |
US4744989A (en) * | 1984-02-08 | 1988-05-17 | E. R. Squibb & Sons, Inc. | Method of preparing liposomes and products produced thereby |
JPH0753661B2 (ja) * | 1984-03-08 | 1995-06-07 | フアレス フアーマスーチカル リサーチ エヌブイ | プロ―リポソーム組成物及びリポソームの水性分散物を作る方法 |
SE8601457D0 (sv) * | 1986-04-01 | 1986-04-01 | Draco Ab | Compositions of liposomes and b?712-receptor active substances for inhalation |
SE8603812D0 (sv) * | 1986-09-12 | 1986-09-12 | Draco Ab | Administration of liposomes to mammals |
US5096629A (en) * | 1988-08-29 | 1992-03-17 | 501 Nippon Fine Chemical Co., Ltd. | Method for preparing lipid powder for use in preparing liposomes and method for preparing liposomes |
CA2087902C (fr) * | 1992-02-05 | 2006-10-17 | Narendra Raghunathji Desai | Compositions liposomiques renfermant des photosensibilisateurs a base de porphyrine |
CA2168656C (fr) * | 1993-08-06 | 2007-09-18 | Yechezkel Barenholz | Methode de preparation de vesicules chargees de structures biologiques, de biopolymeres et (ou) d'oligomeres |
US5635206A (en) * | 1994-01-20 | 1997-06-03 | Hoffmann-La Roche Inc. | Process for liposomes or proliposomes |
AR002009A1 (es) * | 1994-12-22 | 1998-01-07 | Astra Ab | Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco. |
-
1995
- 1995-12-18 AR ARP950100614A patent/AR002009A1/es unknown
- 1995-12-18 SA SA95160463A patent/SA95160463B1/ar unknown
- 1995-12-19 IL IL11645495A patent/IL116454A/en not_active IP Right Cessation
- 1995-12-19 TW TW084113555A patent/TW508248B/zh not_active IP Right Cessation
- 1995-12-20 ES ES95942357T patent/ES2194931T3/es not_active Expired - Lifetime
- 1995-12-20 AU AU43605/96A patent/AU693632B2/en not_active Ceased
- 1995-12-20 PT PT95942357T patent/PT800383E/pt unknown
- 1995-12-20 WO PCT/SE1995/001560 patent/WO1996019199A1/fr active IP Right Grant
- 1995-12-20 DK DK95942357T patent/DK0800383T3/da active
- 1995-12-20 NZ NZ298180A patent/NZ298180A/xx unknown
- 1995-12-20 UA UA97073873A patent/UA43886C2/uk unknown
- 1995-12-20 MY MYPI95003994A patent/MY114114A/en unknown
- 1995-12-20 PL PL95320825A patent/PL184393B1/pl not_active IP Right Cessation
- 1995-12-20 SK SK814-97A patent/SK284918B6/sk unknown
- 1995-12-20 KR KR1019970704253A patent/KR100432461B1/ko not_active IP Right Cessation
- 1995-12-20 RU RU97112399/14A patent/RU2162689C2/ru not_active IP Right Cessation
- 1995-12-20 BR BR9510512A patent/BR9510512A/pt not_active IP Right Cessation
- 1995-12-20 HU HU9800352A patent/HUT77628A/hu unknown
- 1995-12-20 US US08/617,918 patent/US6045828A/en not_active Expired - Lifetime
- 1995-12-20 CA CA002208517A patent/CA2208517A1/fr not_active Abandoned
- 1995-12-20 JP JP8519738A patent/JPH10510830A/ja not_active Ceased
- 1995-12-20 EE EE9700134A patent/EE03592B1/xx not_active IP Right Cessation
- 1995-12-20 AT AT95942357T patent/ATE240095T1/de not_active IP Right Cessation
- 1995-12-20 EP EP95942357A patent/EP0800383B1/fr not_active Expired - Lifetime
- 1995-12-20 CN CN95196978A patent/CN1087932C/zh not_active Expired - Fee Related
- 1995-12-20 DE DE69530792T patent/DE69530792T2/de not_active Expired - Lifetime
- 1995-12-20 CZ CZ19971948A patent/CZ286469B6/cs not_active IP Right Cessation
- 1995-12-21 EG EG106095A patent/EG23683A/xx active
- 1995-12-21 TR TR95/01633A patent/TR199501633A1/xx unknown
-
1997
- 1997-06-06 IS IS4500A patent/IS1978B/is unknown
- 1997-06-19 NO NO19972847A patent/NO320434B1/no unknown
- 1997-06-19 FI FI972653A patent/FI972653A/fi not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0800383T3 (da) | Farmaceutisk præparat, der omfatter proliposompulver til inhalation | |
DK1035833T3 (da) | Sammensætning til nasal indgivelse | |
IL135920A0 (en) | 2-aryl -8-oxodihydropurine derivative, process for the preparation thereof, pharmaceutical composition containing the same and intermediate therefor | |
ZA917528B (en) | Nasal pharmaceutical composition. | |
NO990272L (no) | Pulver-inhalator | |
HK1022271A1 (en) | Pharmaceutical aerosol composition. | |
EE200400122A (et) | Pulberinhalaator | |
HUP0001153A3 (en) | Chemically modified polypeptides, process for producing thereof, pharmaceutical compositions comprising these polypeptides and their use | |
HK1027957A1 (en) | Pharmaceutical composition. | |
HK1028352A1 (en) | Solid pharmaceutical composition containing benzofurane derivatives. | |
IL139529A0 (en) | Platinum complexes, processes for the preparation thereof and pharmaceutical compositions containing the same | |
IL137494A0 (en) | Polypeptide compounds, process for the preparation thereof and pharmaceutical compositions containing the same | |
IL112443A0 (en) | Heterocyclic compounds, their preparation and pharmaceutical compositions containing them | |
HK1015789A1 (en) | Propanolamine derivatives, processes for their preparation, pharmaceuticals comprising these compounds, and their use. | |
HUP0004561A3 (en) | Dihydrobenzofurans, pharmaceutical compositions containing them and use thereof | |
ZA989680B (en) | Pharmaceutical composition. | |
HUP0003207A3 (en) | Proliposome powders for inhalation stabilised by tocopherol, pharmaceutical compositions containing the same and the use of them | |
ZA987392B (en) | Pharmaceutical composition. | |
IL139528A0 (en) | Platinum complexes, processes for the preparation thereof and pharmaceutical compositions containing the same | |
GB9310075D0 (en) | New mercapto-amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same | |
GB9025509D0 (en) | New amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same | |
NO20003182L (no) | FremgangsmÕte for inhalering av pulverstoffer | |
HUP0004292A3 (en) | H3 receptor ligands of the phenyl-alkyl-imidazoles type, pharmaceutical compositions containing them and their use | |
DK0806949T3 (da) | Ny farmaceutisk komposition, der indeholder trimebutin, og fremgangsmåde til fremstilling deraf | |
GB9502257D0 (en) | New diazacyclic compounds,processes for the preparation thereof and pharmaceutical composition comprising the same |